2Bosari S, Moneghini L, Graziani D, et al. Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol, 1995,26:534-540.
3Manne U, Myers RB, Moron C, et al. Prognostic significance of bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer, 1997,74:346-358.
4Silvestrini R, Veneroni S, Daidone MG, et al. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node negative breast cancer patients. J Natl Cancer Inst, 1994,86:499-504.
2Lam KY,Lo CY,Wat NM,et al.The clinicopathological features and importance of p53,Rb,and mdm2 expression in phaeochromocytomas and paragangliomas[J].J Clin Pathol,2001,54(6):443-448.
6Larn KY, Lo CY, Wat NM. The clinicopathological features and importance of p53, Bb, and mdm2 expression in phaeochromocytomas and paragangliomas [J]. J Clin Pathol, 2001, 54 (6): 443-448.
7ComptonCC. Colorectal carcinoma: Diagnostic, prognostic, and molecnlar features[ J]. Mod Pathol,2003,16 (4) :376 - 388.
8EI - Deiry W, Tokino T, Velculescu VE, et al. WAF1, a potential mediater of P53 tumour suppression [ J ]. Cell, 1993, 75 : 817 -825.
